ATLAS fair value
CN¥3.13
Above fair value · 167% premium
Nanhua Bio Medicine stock price today, ATLAS forecast and fair value
Healthcare · Biotechnology · Shenzhen Stock Exchange · China
Prices as of Oct 27, 2026 · CNY
CN¥3.13
Above fair value · 167% premium
47%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS estimates Nanhua Bio Medicine's fair value at about CN¥3.13 per share (reasonable range: CN¥2.54 to CN¥4.24). At CN¥8.37, the stock trades 167% above it.
It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is low. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Nanhua Bio Medicine a 47% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between CN¥7.36 and CN¥9.27; in 9 out of 10, between CN¥6.00 and CN¥11.38. Estimated annual volatility is 70%.
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Nanhua Bio Medicine sits above fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks 000504.SHE has traded between CN¥7.02 and CN¥14.04. Today it is 40.4% below that high and 19% above its low.
On the business: net margin is 5.8%; it trades at 81.3 times earnings.
Its beta is 0.34: it tends to move less than the market.
Landfar Bio-medicine Co., Ltd operates as a biomedical technology company. It operates in two segments, Biomedicine, and Energy Saving and Environmental Protection.
Want to see everything about Nanhua Bio Medicine?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
About CN¥3.13 per share according to ATLAS (reasonable range: CN¥2.54 to CN¥4.24). With the stock at CN¥8.37, it is 167% above it.
47%: close to a coin flip. In half of the simulated outcomes, 000504.SHE ends the month between CN¥7.36 and CN¥9.27.
Nanhua Bio Medicine's market capitalization is CN¥3.2B. Its price-to-earnings (P/E) ratio is 81.3: you pay CN¥81.3 for each CN¥1.00 of yearly earnings.
ATLAS estimates annual volatility at 70%. In a typical month, half of the outcomes end between CN¥7.36 and CN¥9.27.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy